¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÀåÇÐȸ ½ÉÀμº¼îÅ©¿¬±¸È¸ Á¦ 3ȸ ½ÉÆ÷Áö¾ö : 2023-05-27

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѽÉÀåÇÐȸ ½ÉÀμº¼îÅ©¿¬±¸È¸ Á¦ 3ȸ ½ÉÆ÷Áö¾ö : 2023-05-27
±³À°ÀÏÀÚ : 2023-05-27
±³À°Àå¼Ò : ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦

±³À°ÁÖÁ¦ : ´ëÇѽÉÀåÇÐȸ ½ÉÀμº¼îÅ©¿¬±¸È¸ Á¦ 3ȸ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀμº¼îÅ©¿¬±¸È¸

´ã´çÀÚ : ±èÀºÁø
¿¬¶ôó : 02-3410-6475

À̸ÞÀÏ : kscwg2021@gmail.com

±³À°Á¾·ù : ³»°ú, ÈäºÎ¿Ü°ú

Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 45ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:05~09:20 Consumptive coagulopathy and anti-coagulation therapy Àå¿ìÁø(ÀÌ´ë¼­¿ïº´¿ø)

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:20~09:35 Central ECMO: when? whom? È«Á¤¾Ö(ÇѸ²´ë¼º½Éº´¿ø)

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:35~09:50 Infection surveillance and antibiotics selection À§Áø(°¡Ãµ´ë ±æº´¿ø)

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:50~10:05 Transfusion strategy: is it different from other critically-ill conditions? ±èÈñÁß(°í´ë¾È¾Ïº´¿ø)

Åä·Ð 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:05~10:30 Åä·Ð ( )

ÈÞ½Ä 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:30~10:40 ÈÞ½Ä ( )

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:40~10:55 AMI: revascularization strategy including CABG and MCS timing ±è¹Îö(Àü³²´ëº´¿ø)

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:55~11:10 Heart failure related cardiogenic shock: inotropes, vasopressor, MCS transition À̼ö¿ë(¾ç»êºÎ»ê´ëº´¿ø)

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:10~11:25 Fulminant Myocarditis: optimal timing of biopsy, MCS, and cardiac replacement therapy Á¶Çü¿ø(ºÐ´ç¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:25~11:40 Mixed or undifferentiated shock ±è¾Æ¶÷(¼­¿ï¾Æ»êº´¿ø)

Åä·Ð 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:40~12:00 Åä·Ð ( )

½Ä»ç 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 12:00~13:00 ½Ä»ç ( )

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:00~13:15 RESCUE SHOCK trial and CLEAN ECMO trial ¾çÁ¤ÈÆ(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:15~13:30 Timing of LV unloading and limb ischemia proctection in VA-ECMO ±è¹Î¼®(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:30~13:45 International ongoing trials on CS °­ÁöÈÆ(¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:45~14:00 Perspectives in Cardiogenic Shock in Korea ±ÇÇöö(»ï¼º¼­¿ïº´¿ø)

Åä·Ð 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:00~14:20 Åä·Ð ( )

ÈÞ½Ä 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:20~14:30 ÈÞ½Ä ( )

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:30~14:50 ºòµ¥ÀÌÅ͸¦ ÅëÇÑ Çѱ¹Àο¡¼­ ½ÉÀμº¼îÅ©ÀÇ Ä¡·á ÇöȲ ÃÖ±âÈ«(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:50~15:10 Àü¹®°¡ ¼³¹®À» ÅëÇÑ ÇöÀçÀÇ ¹®Á¦Á¡°ú ÇØ°á ¹æÇâÀÇ ¿ì¼±¼øÀ§ °­´Üºñ(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:10~15:30 ½ÉÀå³»¿Ü°ú ÁßȯÀڽǿ¡¼­ Suregen ÁßȯÀÚ Àü´ãÀÇÀÇ ¿ªÇÒ°ú ÀÚ°ÝÀº ¹«¾ùÀΰ¡? ÀåÇü¿ì(ºÐ´ç¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:30~15:50 ÁßȯÀÚ½Ç »ýÁ¸ÀÚµéÀÇ ÀÏ»ó»ýÈ°·ÎÀÇ º¹±Í´Â ¾î¶»°Ô ÀÌ·ç¾îÁ®¾ßÇϴ°¡? À̸¸Á¾(ÀÎÇϴ뺴¿ø)

Åä·Ð 05¿ù 27ÀÏ ÀÏ¿ø¿ª »ï¼º»ý¸íºôµù È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:50~16:10 Åä·Ð ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÀåÇÐȸ ½ÉÀμº¼îÅ©¿¬±¸È¸ Á¦ 3ȸ ½ÉÆ÷Áö¾ö : 2023-05-27""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2023 »ó¹Ý±â Àü°øÀǸ¦ À§ÇÑ ÀÌ°úÇÐ ±æ¶óÀâÀÌ : 2023-05-28
´ÙÀ½±Û 2023³âµµ ¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ Á¤Çü¿Ü°ú±³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2023-05-27
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20835 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ 2024³â Á¦ 1ȸ ³»½Ã°æ Áý´ãȸ : 2024-06-21 0 4 2024-05-27
20834 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ)¾È°ú ±Ý¿äÁý´ãȸ : 2024-06-21 0 1 2024-05-27
20833 ¼­¿ï ´ëÇѳúÀüÁõÇÐȸ 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 1ÀÏÂ÷ : 2024-06-21 0 2 2024-05-27
20832 ¼­¿ï Á¦8Â÷ µµºÀ±¸ÀÇ»çȸ Çмú¼¼¹Ì³ª(½ÉÇ÷°üÁúȯ ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·á, ºÒ¸éÁõ, Ä¡¸Å¾à¹°Ä¡·á, Ç×Ç÷ÀüÁ¦) : 2024-06-21 0 0 2024-05-27
20831 ºÎ»ê 2024³âµµ ºÎ»ê․°æ³²Áö¿ª ÀÇ°ú´ëÇÐ ½ÅÀÓ±³¼ö ¿öÅ©¼ó (2ÀÏÂ÷) : 2024-06-21 0 1 2024-05-27
20830 Á¦ÁÖ ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-06-21 0 0 2024-05-27
20829 ¼­¿ï 2024³â °áÇÙ°ü¸®±³À° 2±â(1ÀÏÂ÷) : 2024-06-20 0 0 2024-05-27
20828 ºÎ»ê ´ëÇѼҾÆû¼Ò³â°úÇÐȸ ºÎ»êÁöȸ Áý´ãȸ : 2024-06-20 0 5 2024-05-27
20827 ºÎ»ê ´ëÇѾȰúÇÐȸ ºÎ»êÁöȸ Á¦ 510ȸ ÇмúÁý´ãȸ : 2024-06-20 0 1 2024-05-27
20826 ºÎ»ê 2024³âµµ ºÎ»ê․°æ³²Áö¿ª ÀÇ°ú´ëÇÐ ½ÅÀÓ±³¼ö ¿öÅ©¼ó (1ÀÏÂ÷) : 2024-06-20 0 0 2024-05-27
20825 ¼­¿ï (¿Â¶óÀÎ) ´ëÇÑÅëÁõÇÐȸ ¼­¿ïÁöȸ Áý´ãȸ : 2024-06-20 0 0 2024-05-27
20824 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À°(¼­½Ä ÀÛ¼º ½ÇÁ¦) : 2024-06-20 0 0 2024-05-27
20823 °æ±â µ¿±¹´ëÇб³ Àϻ꺴¿ø : °ñ°üÀý¿°ÀÇ Áø´Ü ¹× Ä¡·á : 2024-06-19 0 2 2024-05-27
20822 °æ±â ´ëÇÑ°£ÇÐȸ Overlooked Liver Diseases : 2024-06-19 0 7 2024-05-27
20821 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦2ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-06-17 0 4 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷